Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬African trypanosomiasis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬1. African trypanosomiasis
|
||||||||||||||||||||||||||||||||
2 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬African trypanosomiasis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
3 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬African trypanosomiasis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
4 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬African trypanosomiasis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬4. African trypanosomiasis
|
||||||||||||||||||||||||||||||||
5 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬African trypanosomiasis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬5. African trypanosomiasis
|
||||||||||||||||||||||||||||||||
6 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬AGE-RAGE signaling pathway in diabetic complications
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬6. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||
7 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬AGE-RAGE signaling pathway in diabetic complications
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
8 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬AGE-RAGE signaling pathway in diabetic complications
| Lutikizumab | 046 [3] 46, 96, 97 💬8. AGE-RAGE signaling pathway in diabetic complications |
||||||||||||||||||||||||||||||||
9 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬AGE-RAGE signaling pathway in diabetic complications
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬9. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||
10 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬AGE-RAGE signaling pathway in diabetic complications
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬10. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||
11 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Alcoholic liver disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬11. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||
12 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Alcoholic liver disease
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
13 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Alcoholic liver disease
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
14 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Alcoholic liver disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬14. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||
15 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Alcoholic liver disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬15. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||
16 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Alzheimer disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬16. Alzheimer disease
|
||||||||||||||||||||||||||||||||
17 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Alzheimer disease
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
18 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Alzheimer disease
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
19 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Alzheimer disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬19. Alzheimer disease
|
||||||||||||||||||||||||||||||||
20 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Alzheimer disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬20. Alzheimer disease
|
||||||||||||||||||||||||||||||||
21 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Amoebiasis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬21. Amoebiasis
|
||||||||||||||||||||||||||||||||
22 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Amoebiasis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
23 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Amoebiasis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
24 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Amoebiasis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬24. Amoebiasis
|
||||||||||||||||||||||||||||||||
25 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Amoebiasis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬25. Amoebiasis
|
||||||||||||||||||||||||||||||||
26 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬C-type lectin receptor signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬26. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||
27 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬C-type lectin receptor signaling pathway
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
28 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬C-type lectin receptor signaling pathway
| Lutikizumab | 046 [3] 46, 96, 97 💬28. C-type lectin receptor signaling pathway |
||||||||||||||||||||||||||||||||
29 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬C-type lectin receptor signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬29. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||
30 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬C-type lectin receptor signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬30. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||
31 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Chagas disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬31. Chagas disease
|
||||||||||||||||||||||||||||||||
32 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Chagas disease
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
33 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Chagas disease
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
34 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Chagas disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬34. Chagas disease
|
||||||||||||||||||||||||||||||||
35 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Chagas disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬35. Chagas disease
|
||||||||||||||||||||||||||||||||
36 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Coronavirus disease - COVID-19
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬36. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||
37 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Coronavirus disease - COVID-19
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
38 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Coronavirus disease - COVID-19
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
39 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Coronavirus disease - COVID-19
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬39. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||
40 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Coronavirus disease - COVID-19
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬40. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||
41 | Cytokine-cytokine receptor interaction 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Cytokine-cytokine receptor interaction
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬41. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||
42 | Cytokine-cytokine receptor interaction 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Cytokine-cytokine receptor interaction
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
43 | Cytokine-cytokine receptor interaction 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Cytokine-cytokine receptor interaction
| Lutikizumab | 046 [3] 46, 96, 97 💬43. Cytokine-cytokine receptor interaction |
||||||||||||||||||||||||||||||||
44 | Cytokine-cytokine receptor interaction 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Cytokine-cytokine receptor interaction
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬44. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||
45 | Cytokine-cytokine receptor interaction 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Cytokine-cytokine receptor interaction
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬45. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||
46 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Cytosolic DNA-sensing pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬46. Cytosolic DNA-sensing pathway
|
||||||||||||||||||||||||||||||||
47 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Cytosolic DNA-sensing pathway
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
48 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Cytosolic DNA-sensing pathway
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
49 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Cytosolic DNA-sensing pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬49. Cytosolic DNA-sensing pathway
|
||||||||||||||||||||||||||||||||
50 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Cytosolic DNA-sensing pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬50. Cytosolic DNA-sensing pathway
|
||||||||||||||||||||||||||||||||
51 | Fluid shear stress and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Fluid shear stress and atherosclerosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬51. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||
52 | Fluid shear stress and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Fluid shear stress and atherosclerosis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
53 | Fluid shear stress and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Fluid shear stress and atherosclerosis
| Lutikizumab | 046 [3] 46, 96, 97 💬53. Fluid shear stress and atherosclerosis |
||||||||||||||||||||||||||||||||
54 | Fluid shear stress and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Fluid shear stress and atherosclerosis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬54. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||
55 | Fluid shear stress and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Fluid shear stress and atherosclerosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬55. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||
56 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Graft-versus-host disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬56. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||
57 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Graft-versus-host disease
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
58 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Graft-versus-host disease
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
59 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Graft-versus-host disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬59. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||
60 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Graft-versus-host disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬60. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||
61 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Hematopoietic cell lineage
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬61. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||
62 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Hematopoietic cell lineage
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
63 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Hematopoietic cell lineage
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
64 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Hematopoietic cell lineage
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬64. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||
65 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Hematopoietic cell lineage
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬65. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||
66 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Herpes simplex virus 1 infection
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬66. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||
67 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Herpes simplex virus 1 infection
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
68 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Herpes simplex virus 1 infection
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
69 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Herpes simplex virus 1 infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬69. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||
70 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Herpes simplex virus 1 infection
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬70. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||
71 | Human cytomegalovirus infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Human cytomegalovirus infection
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬71. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||
72 | Human cytomegalovirus infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Human cytomegalovirus infection
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
73 | Human cytomegalovirus infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Human cytomegalovirus infection
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
74 | Human cytomegalovirus infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Human cytomegalovirus infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬74. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||
75 | Human cytomegalovirus infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Human cytomegalovirus infection
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬75. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||
76 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬IL-17 signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬76. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||
77 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬IL-17 signaling pathway
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
78 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬IL-17 signaling pathway
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
79 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬IL-17 signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬79. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||
80 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬IL-17 signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬80. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||
81 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Inflammatory bowel disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬81. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||
82 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Inflammatory bowel disease
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
83 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Inflammatory bowel disease
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
84 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Inflammatory bowel disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬84. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||
85 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Inflammatory bowel disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬85. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||
86 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Inflammatory mediator regulation of TRP channels
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬86. Inflammatory mediator regulation of TRP channels
|
||||||||||||||||||||||||||||||||
87 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Inflammatory mediator regulation of TRP channels
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
88 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Inflammatory mediator regulation of TRP channels
| Lutikizumab | 046 [3] 46, 96, 97 💬88. Inflammatory mediator regulation of TRP channels |
||||||||||||||||||||||||||||||||
89 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Inflammatory mediator regulation of TRP channels
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬89. Inflammatory mediator regulation of TRP channels
|
||||||||||||||||||||||||||||||||
90 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Inflammatory mediator regulation of TRP channels
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬90. Inflammatory mediator regulation of TRP channels
|
||||||||||||||||||||||||||||||||
91 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Influenza A
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬91. Influenza A
|
||||||||||||||||||||||||||||||||
92 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Influenza A
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
93 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Influenza A
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
94 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Influenza A
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬94. Influenza A
|
||||||||||||||||||||||||||||||||
95 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Influenza A
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬95. Influenza A
|
||||||||||||||||||||||||||||||||
96 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Legionellosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬96. Legionellosis
|
||||||||||||||||||||||||||||||||
97 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Legionellosis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
98 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Legionellosis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
99 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Legionellosis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬99. Legionellosis
|
||||||||||||||||||||||||||||||||
100 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Legionellosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬100. Legionellosis
|
||||||||||||||||||||||||||||||||
101 | Leishmaniasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Leishmaniasis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬101. Leishmaniasis
|
||||||||||||||||||||||||||||||||
102 | Leishmaniasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Leishmaniasis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
103 | Leishmaniasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Leishmaniasis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
104 | Leishmaniasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Leishmaniasis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬104. Leishmaniasis
|
||||||||||||||||||||||||||||||||
105 | Leishmaniasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Leishmaniasis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬105. Leishmaniasis
|
||||||||||||||||||||||||||||||||
106 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Lipid and atherosclerosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬106. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||
107 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Lipid and atherosclerosis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
108 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Lipid and atherosclerosis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
109 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Lipid and atherosclerosis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬109. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||
110 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Lipid and atherosclerosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬110. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||
111 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Malaria
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬111. Malaria
|
||||||||||||||||||||||||||||||||
112 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Malaria
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
113 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Malaria
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
114 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Malaria
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬114. Malaria
|
||||||||||||||||||||||||||||||||
115 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Malaria
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬115. Malaria
|
||||||||||||||||||||||||||||||||
116 | MAPK signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬MAPK signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬116. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||
117 | MAPK signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬MAPK signaling pathway
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
118 | MAPK signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬MAPK signaling pathway
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
119 | MAPK signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬MAPK signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬119. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||
120 | MAPK signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬MAPK signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬120. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||
121 | Measles 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Measles
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬121. Measles
|
||||||||||||||||||||||||||||||||
122 | Measles 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Measles
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
123 | Measles 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Measles
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
124 | Measles 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Measles
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬124. Measles
|
||||||||||||||||||||||||||||||||
125 | Measles 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Measles
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬125. Measles
|
||||||||||||||||||||||||||||||||
126 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Necroptosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬126. Necroptosis
|
||||||||||||||||||||||||||||||||
127 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Necroptosis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
128 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Necroptosis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
129 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Necroptosis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬129. Necroptosis
|
||||||||||||||||||||||||||||||||
130 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Necroptosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬130. Necroptosis
|
||||||||||||||||||||||||||||||||
131 | NF-kappa B signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬NF-kappa B signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬131. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||
132 | NF-kappa B signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬NF-kappa B signaling pathway
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
133 | NF-kappa B signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬NF-kappa B signaling pathway
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
134 | NF-kappa B signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬NF-kappa B signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬134. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||
135 | NF-kappa B signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬NF-kappa B signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬135. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||
136 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬NOD-like receptor signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬136. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
137 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬NOD-like receptor signaling pathway
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
138 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬NOD-like receptor signaling pathway
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
139 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬NOD-like receptor signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬139. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
140 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬NOD-like receptor signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬140. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
141 | Non-alcoholic fatty liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Non-alcoholic fatty liver disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬141. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||
142 | Non-alcoholic fatty liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Non-alcoholic fatty liver disease
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
143 | Non-alcoholic fatty liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Non-alcoholic fatty liver disease
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
144 | Non-alcoholic fatty liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Non-alcoholic fatty liver disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬144. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||
145 | Non-alcoholic fatty liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Non-alcoholic fatty liver disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬145. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||
146 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Osteoclast differentiation
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬146. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||
147 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Osteoclast differentiation
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
148 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Osteoclast differentiation
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
149 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Osteoclast differentiation
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬149. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||
150 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Osteoclast differentiation
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬150. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||
151 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Pathogenic Escherichia coli infection
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬151. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||
152 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Pathogenic Escherichia coli infection
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
153 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Pathogenic Escherichia coli infection
| Lutikizumab | 046 [3] 46, 96, 97 💬153. Pathogenic Escherichia coli infection |
||||||||||||||||||||||||||||||||
154 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Pathogenic Escherichia coli infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬154. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||
155 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Pathogenic Escherichia coli infection
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬155. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||
156 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Pathways of neurodegeneration - multiple diseases
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬156. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||
157 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Pathways of neurodegeneration - multiple diseases
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
158 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Pathways of neurodegeneration - multiple diseases
| Lutikizumab | 046 [3] 46, 96, 97 💬158. Pathways of neurodegeneration - multiple diseases |
||||||||||||||||||||||||||||||||
159 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Pathways of neurodegeneration - multiple diseases
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬159. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||
160 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Pathways of neurodegeneration - multiple diseases
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬160. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||
161 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Pertussis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬161. Pertussis
|
||||||||||||||||||||||||||||||||
162 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Pertussis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
163 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Pertussis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
164 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Pertussis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬164. Pertussis
|
||||||||||||||||||||||||||||||||
165 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Pertussis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬165. Pertussis
|
||||||||||||||||||||||||||||||||
166 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Prion disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬166. Prion disease
|
||||||||||||||||||||||||||||||||
167 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Prion disease
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
168 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Prion disease
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
169 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Prion disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬169. Prion disease
|
||||||||||||||||||||||||||||||||
170 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Prion disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬170. Prion disease
|
||||||||||||||||||||||||||||||||
171 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Rheumatoid arthritis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬171. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||
172 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Rheumatoid arthritis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
173 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Rheumatoid arthritis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
174 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Rheumatoid arthritis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬174. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||
175 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Rheumatoid arthritis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬175. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||
176 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Salmonella infection
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬176. Salmonella infection
|
||||||||||||||||||||||||||||||||
177 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Salmonella infection
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
178 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Salmonella infection
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
179 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Salmonella infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬179. Salmonella infection
|
||||||||||||||||||||||||||||||||
180 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Salmonella infection
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬180. Salmonella infection
|
||||||||||||||||||||||||||||||||
181 | Shigellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Shigellosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬181. Shigellosis
|
||||||||||||||||||||||||||||||||
182 | Shigellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Shigellosis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
183 | Shigellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Shigellosis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
184 | Shigellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Shigellosis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬184. Shigellosis
|
||||||||||||||||||||||||||||||||
185 | Shigellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Shigellosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬185. Shigellosis
|
||||||||||||||||||||||||||||||||
186 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Th17 cell differentiation
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬186. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||
187 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Th17 cell differentiation
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
188 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Th17 cell differentiation
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
189 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Th17 cell differentiation
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬189. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||
190 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Th17 cell differentiation
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬190. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||
191 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬TNF signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬191. TNF signaling pathway
|
||||||||||||||||||||||||||||||||
192 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬TNF signaling pathway
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
193 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬TNF signaling pathway
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
194 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬TNF signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬194. TNF signaling pathway
|
||||||||||||||||||||||||||||||||
195 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬TNF signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬195. TNF signaling pathway
|
||||||||||||||||||||||||||||||||
196 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Toll-like receptor signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬196. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
197 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Toll-like receptor signaling pathway
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
198 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Toll-like receptor signaling pathway
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
199 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Toll-like receptor signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬199. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
200 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Toll-like receptor signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬200. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
201 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Tuberculosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬201. Tuberculosis
|
||||||||||||||||||||||||||||||||
202 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Tuberculosis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
203 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Tuberculosis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
204 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Tuberculosis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬204. Tuberculosis
|
||||||||||||||||||||||||||||||||
205 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Tuberculosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬205. Tuberculosis
|
||||||||||||||||||||||||||||||||
206 | Type I diabetes mellitus 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Type I diabetes mellitus
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬206. Type I diabetes mellitus
|
||||||||||||||||||||||||||||||||
207 | Type I diabetes mellitus 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Type I diabetes mellitus
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
208 | Type I diabetes mellitus 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Type I diabetes mellitus
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
209 | Type I diabetes mellitus 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Type I diabetes mellitus
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬209. Type I diabetes mellitus
|
||||||||||||||||||||||||||||||||
210 | Type I diabetes mellitus 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Type I diabetes mellitus
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬210. Type I diabetes mellitus
|
||||||||||||||||||||||||||||||||
211 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Yersinia infection
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬211. Yersinia infection
|
||||||||||||||||||||||||||||||||
212 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Yersinia infection
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
213 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Yersinia infection
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
214 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Yersinia infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬214. Yersinia infection
|
||||||||||||||||||||||||||||||||
215 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Yersinia infection
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬215. Yersinia infection
|
African trypanosomiasis
1 gene, 5 drugs (DrugBank) and 23 diseases
AGE-RAGE signaling pathway in diabetic complications
1 gene, 5 drugs (DrugBank) and 23 diseases
Alcoholic liver disease
1 gene, 5 drugs (DrugBank) and 23 diseases
Alzheimer disease
1 gene, 5 drugs (DrugBank) and 23 diseases
Amoebiasis
1 gene, 5 drugs (DrugBank) and 23 diseases
C-type lectin receptor signaling pathway
1 gene, 5 drugs (DrugBank) and 23 diseases
Chagas disease
1 gene, 5 drugs (DrugBank) and 23 diseases
Coronavirus disease - COVID-19
1 gene, 5 drugs (DrugBank) and 23 diseases
Cytokine-cytokine receptor interaction
1 gene, 5 drugs (DrugBank) and 23 diseases
Cytosolic DNA-sensing pathway
1 gene, 5 drugs (DrugBank) and 23 diseases
Fluid shear stress and atherosclerosis
1 gene, 5 drugs (DrugBank) and 23 diseases
Graft-versus-host disease
1 gene, 5 drugs (DrugBank) and 23 diseases
Hematopoietic cell lineage
1 gene, 5 drugs (DrugBank) and 23 diseases
Herpes simplex virus 1 infection
1 gene, 5 drugs (DrugBank) and 23 diseases
Human cytomegalovirus infection
1 gene, 5 drugs (DrugBank) and 23 diseases
IL-17 signaling pathway
1 gene, 5 drugs (DrugBank) and 23 diseases
Inflammatory bowel disease
1 gene, 5 drugs (DrugBank) and 23 diseases
Inflammatory mediator regulation of TRP channels
1 gene, 5 drugs (DrugBank) and 23 diseases
Influenza A
1 gene, 5 drugs (DrugBank) and 23 diseases
Legionellosis
1 gene, 5 drugs (DrugBank) and 23 diseases
Leishmaniasis
1 gene, 5 drugs (DrugBank) and 23 diseases
Lipid and atherosclerosis
1 gene, 5 drugs (DrugBank) and 23 diseases
Malaria
1 gene, 5 drugs (DrugBank) and 23 diseases
MAPK signaling pathway
1 gene, 5 drugs (DrugBank) and 23 diseases
Measles
1 gene, 5 drugs (DrugBank) and 23 diseases
Necroptosis
1 gene, 5 drugs (DrugBank) and 23 diseases
NF-kappa B signaling pathway
1 gene, 5 drugs (DrugBank) and 23 diseases
NOD-like receptor signaling pathway
1 gene, 5 drugs (DrugBank) and 23 diseases
Non-alcoholic fatty liver disease
1 gene, 5 drugs (DrugBank) and 23 diseases
Osteoclast differentiation
1 gene, 5 drugs (DrugBank) and 23 diseases
Pathogenic Escherichia coli infection
1 gene, 5 drugs (DrugBank) and 23 diseases
Pathways of neurodegeneration - multiple diseases
1 gene, 5 drugs (DrugBank) and 23 diseases
Pertussis
1 gene, 5 drugs (DrugBank) and 23 diseases
Prion disease
1 gene, 5 drugs (DrugBank) and 23 diseases
Rheumatoid arthritis
1 gene, 5 drugs (DrugBank) and 23 diseases
Salmonella infection
1 gene, 5 drugs (DrugBank) and 23 diseases
Shigellosis
1 gene, 5 drugs (DrugBank) and 23 diseases
Th17 cell differentiation
1 gene, 5 drugs (DrugBank) and 23 diseases
TNF signaling pathway
1 gene, 5 drugs (DrugBank) and 23 diseases
Toll-like receptor signaling pathway
1 gene, 5 drugs (DrugBank) and 23 diseases
Tuberculosis
1 gene, 5 drugs (DrugBank) and 23 diseases
Type I diabetes mellitus
1 gene, 5 drugs (DrugBank) and 23 diseases
Yersinia infection
1 gene, 5 drugs (DrugBank) and 23 diseases